WNK4 kinase regulates surface expression of the human sodium chloride cotransporter in mammalian cells

Kidney International

Volumn 69, Issue 12, 2006, Pages 2162-2170

  Cai, H ^a   Cebotaru, V ^a   Wang, Y H ^a   Zhang, X M ^a   Cebotaru, L ^a   Guggino, S E ^a   Guggino, W B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cotransporter; Dynamin; Lysosomal pathway; Pseudohypoaldosteronism type II; Sodium chloride; WNK4 kinase

Indexed keywords

BAFILOMYCIN A1; DYNAMIN; ENZYME; PROTEIN; PROTON PUMP INHIBITOR; SODIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG; WITH NO LYSINE K 4 KINASE;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; ENDOCYTOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; XENOPUS;

ANIMALS; BIOTINYLATION; BLOTTING, WESTERN; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DYNAMIN II; DYNAMINS; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; KIDNEY; LYSOSOMES; MUTATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PSEUDOHYPOALDOSTERONISM; SODIUM CHLORIDE SYMPORTERS;

EID: 33745076253     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000333     Document Type: Article

References (35)

1. Xu B, English JM, Wilsbacher JL et al. WNK1, a novel mammalian serine/ threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 2000; 275: 16795-16801.
2. Wilson FH, Disse-Nicodeme S, Choate KA et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112.
3. Simon DB, Nelson-Williams C, Bia MJ et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30.
4. Schambelan M, Sebastian A, Rector Jr FC. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int 1981; 19: 716-727.
5. Take C, Ikeda K, Kurasawa T, Kurokawa K. Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism. N Engl J Med 1991; 324: 472-476.
6. Yang CL, Angell J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003; 111: 1039-1045.
7. Wilson FH, Kahle KT, Sabath E et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 2003; 100: 680-684.
8. Yang CL, Zhu X, Wang Z et al. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest 2005; 115: 1379-1387.
9. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422: 37-44.
10. McNiven MA, Cao H, Pitts KR, Yoon Y. The dynamin family of mechanoenzymes: pinching in new places. Trends Biochem Sci 2000; 25: 115-120.
11. Cao H, Thompson HM, Krueger EW, McNiven MA. Disruption of Golgi structure and function in mammalian cells expressing a mutant dynamin. J Cell Sci 2000; 113(Part 11): 1993-2002.
12. Damke H, Baba T, Warnock DE, Schmid SL. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol 1994; 127: 915-934.
13. Drose S, Altendorf K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J Exp Biol 1997; 200: 1-8.
14. + secretion. Nat Genet 2003; 35: 372-376.
15. Kahle KT, Wilson FH, Lalioti M et al. WNK kinases: molecular regulators of integrated epithelial ion transport. Curr Opin Nephrol Hypertens 2004; 13: 557-562.
16. Yamauchi K, Rai T, Kobayashi K et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci USA 2004; 101: 4690-4694.
17. Wyse B, Ali N, Ellison DH. Interaction with grp58 increases activity of the thiazide-sensitive Na-Cl cotransporter. Am J Physiol Renal Physiol 2002; 282: F424-F430.
18. Kunchaparty S, Palcso M, Berkman J et al. Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome. Am J Physiol 1999; 277: F643-F649.
19. Delpire E, Mount DB. Human and murine phenotypes associated with defects in cation-chloride cotransport. Annu Rev Physiol 2002; 64: 803-843.
20. Lemmink HH, Knoers NV, Karolyi L et al. Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int 1998; 54: 720-730.
21. Ecelbarger CA, Knepper MA, Verbalis JG. Increased abundance of distal sodium transporters in rat kidney during vasopressin escape. J Am Soc Nephrol 2001; 12: 207-217.
22. Kim GH, Masilamani S, Turner R et al. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA 1998; 95: 14552-14557.
23. Verlander JW, Tran TM, Zhang L et al. Estradiol enhances thiazide-sensitive NaCl cotransporter density in the apical plasma membrane of the distal convoluted tubule in ovariectomized rats. J Clin Invest 1998; 101: 1661-1669.
24. + transporter abundances in response to chronic thiazide or loop diuretic treatment in rats. Am J Physiol Renal Physiol 2003; 284: F133-F143.
25. Masilamani S, Wang X, Kim GH et al. Time course of renal Na-K-ATPase, NHE3, NKCC2, NCC, and ENaC abundance changes with dietary NaCl restriction. Am J Physiol Renal Physiol 2002; 283: F648-F657.
26. Elkjaer ML, Kwon TH, Wang W et al. Altered expression of renal NHE3, TSC, BSC-1, and ENaC subunits in potassium-depleted rats. Am J Physiol Renal Physiol 2002; 283: F1376-F1388.
27. Vazquez N, Monroy A, Dorantes E et al. Functional differences between flounder and rat thiazide-sensitive Na-Cl cotransporter. Am J Physiol Renal Physiol 2002; 282: F599-F607.
28. Lee MR, Ball SG, Thomas TH, Morgan DB. Hypertension and hyperkalaemia responding to bendrofluazide. Q J Med 1979; 48: 245-258.
29. Lee MR, Morgan DB. Familial hyperkalaemia responsive to benzothiadiazine diuretic. Lancet 1980; 1: 879.
30. Baz M, Berland Y, Dussol B et al. Familial hyperkalemia syndrome (Gordon's syndrome). Presse Med 1990; 19: 1981-1984.
31. Ellison DH, Velazquez H, Wright FS. Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol 1987; 253: F546-F554.
32. Plotkin MD, Kaplan MR, Verlander JW et al. Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney. Kidney Int 1996; 50: 174-183.
33. Gordon RD, Lemm SA, Unny TJ, Towasser M. Gordon syndrome: a sodium-volume dependent form of hypertension with a genetic basis. In: Laragh JH and Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis, and Management. Raven Press: New York, 1995, pp 2111-2123.
34. Mover BD, Loffing J, Schwiebert EM et al. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in Madin-Darby canine kidney cells. J Biol Chem 1998; 273: 21759-21768.
35. Cheng J, Moyer BD, Milewski M et al. A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem 2002; 277: 3520-3529.